The FDA recently released the results of their multi-year opioid product quality survey aimed to detect substitutions of illicit fentanyl in the supply chain of FDA-regulated opioids. The FDA reported no evidence of illegal substitution in any FDA-regulated opioids, ingredients used to make opioids, opioid overdose reversal products, and opioid use disorder (OUD) treatment products tested. Cont.
Senate Appropriators Advance Modest Substance Use, Mental Health Block Grant Increases in Spending B
Last week, the Senate Appropriations Committee passed a FY24 funding bill for several priority agencies including the Substance Abuse and Mental Health Services Administration (SAMHSA), Centers for Di
SAMHSA recently released a new advisory on digital therapeutics for management and treatment in behavioral health. This advisory “...introduces readers to digital therapeutics (DTx) and the benefits o
SAMHSA [18-July] | SAMHSA is marking the one year-anniversary since the 988 Suicide and Crisis Lifeline was launched. In honor of one-year in service, SAMHSA’s 988 Lifeline team has updated the 988 Pa